🇬🇧 Visipaque 270 in United Kingdom

Visipaque 270 (IODIXANOL) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

Visipaque 270 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in United Kingdom

Frequently asked questions

Is Visipaque 270 approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Visipaque 270 in United Kingdom?

GE HealthCare is the originator. The local marketing authorisation holder may differ — check the official source linked above.